| Literature DB >> 35168740 |
Erika Franklin Fowler1, Rebekah H Nagler2, Darshana Banka1, Sarah E Gollust3.
Abstract
Although concerns about politicization of health and science are not new, the COVID-19 pandemic has amplified attention to how political disagreement over scientific guidelines and recommendations might influence attitudes and behaviors about the health topics in question and might even spill or carry over to affect other attitudes important to public health. The literature employs differing definitions of politicization-at times referring to controversy in the public sphere, at others referring to the exploitation of the uncertainty inherent in science, and at still others referring to whether the issue enters political discourse-all of which are viewed as distinct dimensions by the public. What is not known is how these different aspects of politicization influence public attitudes about the health topics and or broader attitudes about scientific guidelines, and-assuming adverse effects-what strategies might be effective at mitigating the consequences. This paper draws on a survey experiment of 3012U.S. respondents fielded in summer 2020 that was designed as a pilot study to assess the effects of different dimensions of politicization. Findings do not suggest that one type of politicization is necessarily more pernicious than the others. In fact, all types of politicization increased negative emotional responses and confusion, both with respect to the health topic in question (HPV vaccine and COVID-19) but also on other domains, although opinions about policy were unaffected. The findings also suggest that inoculation may have potential as a messaging strategy for blunting the adverse effects of exposure to politicization.Entities:
Keywords: Carryover effects; Controversy; Coronavirus (COVID-19); HPV vaccine; Media; Political discourse; Politicization of science; Public health; Public opinion; Uncertainty
Mesh:
Substances:
Year: 2022 PMID: 35168740 PMCID: PMC8839809 DOI: 10.1016/bs.pmbts.2021.11.008
Source DB: PubMed Journal: Prog Mol Biol Transl Sci ISSN: 1877-1173 Impact factor: 3.622
Headlines and inoculation treatments for each of the experimental study conditions.
| HPV vaccine headlines | COVID-19 headlines | Inoculation | |
|---|---|---|---|
| Base | Panel to Expand HPV Vaccine Recommendations | CDC Updates Recommendations on Mask Wearing | |
| +Controversy | Controversy Erupts Over New HPV Vaccine Recommendations | …people…try to make health recommendations seem more controversial than they really are…. They create drama to draw attention away from the large amount of agreement… | |
| +Controversy +Uncertainty | Advocates Cast Doubt on Scientific Evidence Behind New HPV Vaccine Recommendations as Controversy Erupts | …people…try to make health recommendations seem more controversial than they really are, saying that the science is more uncertain than it really is…. They create drama and exaggerate uncertainty to draw attention away from the large amount of scientific agreement… | |
| +Controversy +Political | Political Pushback to New HPV Vaccine Recommendations as Controversy Erupts | …politicians…try to make health recommendations seem more controversial than they really are…. They create drama for political gain to draw attention away from the large amount of bipartisan agreement… | |
| All Politicized Elements | Controversy and Political Pushback Over CDC Mask Wearing Recommendations in Light of Doubts About Scientific Evidence | …politicians or other people…try to make health recommendations seem more controversial than they really are, saying that the science is more uncertain than it really is or that there is more division between Republicans and Democrats than there really is…. They create drama and exaggerate uncertainty to draw attention away from the large amount of scientific and bipartisan agreement… |
Note: News article treatment language varied between the two topics. Each of the politicized conditions added additional language (in addition to the headline changes listed in the table) to the base information to help emphasize the particular treatment which included discussion of heated debate and disagreement and a quote.
Experimental conditions and sample size by topic.
| HPV vaccine | COVID-19 | |||
|---|---|---|---|---|
| No Inoc. | + Inoc. | No Inoc. | + Inoc. | |
| Base | 296 | 303 | ||
| +Controversy | 305 | 308 | ||
| +Controversy +Uncertainty | 286 | 303 | ||
| +Controversy +Political | 300 | 296 | ||
| All Politicized Elements | 302 | 313 | ||
| 2094 | 918 | |||
Fig. 1Effects of politicization treatments on negative emotional reactions (HPV vaccine).
Fig. 2Effects of Politicization treatments on negative emotional reactions (COVID-19).
T-test comparisons of inoculation warnings on negative emotions compared to politicization conditions alone.
| Irritation | Distress | ||||||
|---|---|---|---|---|---|---|---|
| Mean | SE | p | Mean | SE | p | ||
| HPV Vaccine Conditions | 0.92 | 0.21 | |||||
| No Inoc. | 2.14 | 0.065 | 2.08 | 0.070 | |||
| + Inoc. | 2.27 | 0.066 | 2.00 | 0.067 | |||
| 0.78 | 0.92 | ||||||
| No Inoc. | 2.13 | 0.065 | 1.98 | 0.068 | |||
| + Inoc. | 2.20 | 0.063 | 2.11 | 0.066 | |||
| 0.92 | 0.97 | ||||||
| No Inoc. | 2.18 | 0.070 | 2.05 | 0.070 | |||
| + Inoc. | 2.32 | 0.066 | 2.24 | 0.073 | |||
| COVID-19 | 0.99 | 0.99 | |||||
| No Inoc. | 2.70 | 0.074 | 2.39 | 0.074 | |||
| + Inoc. | 2.95 | 0.073 | 2.65 | 0.077 | |||
Note: One-tailed tests that inoculations are lower than regular treatment cells are reported.
Fig. 3Effects of politicization treatments on HPV vaccine requirements.
Fig. 4Effects of politicization treatments on COVID-19 mask requirements.
T-test comparisons of inoculation warnings on policy support compared to politicization conditions alone.
| Support for domain-specific mandates | ||||
|---|---|---|---|---|
| Mean | SE | p | ||
| HPV Vaccine | 0.40 | |||
| No Inoculation | 4.30 | 0.104 | ||
| + Inoculation | 4.34 | 0.106 | ||
| 0.092 | ||||
| No Inoculation | 4.41 | 0.106 | ||
| + Inoculation | 4.60 | 0.098 | ||
| 0.21 | ||||
| No Inoculation | 4.38 | 0.109 | ||
| + Inoculation | 4.5 | 0.106 | ||
| COVID-19 | 0.19 | |||
| No Inoculation | 5.61 | 0.100 | ||
| + Inoculation | 5.73 | 0.088 | ||
Note: One-tailed tests that inoculations are higher than regular treatment cells are reported.
Fig. 5Effects of politicization treatments on confusion and backlash (HPV vaccine).
Fig. 6Effects of politicization treatments on confusion and backlash (COVID-19).
T-test comparisons of inoculation warnings on confusion and backlash compared to politicization conditions alone.
| Confusion | Backlash | ||||||
|---|---|---|---|---|---|---|---|
| Mean | SE | p | Mean | SE | p | ||
| HPV Vaccine | 0.66 | 0.81 | |||||
| No Inoc. | 3.72 | 0.088 | 3.59 | 0.087 | |||
| + Inoc. | 3.77 | 0.090 | 3.70 | 0.091 | |||
| 0.30 | 0.25 | ||||||
| No Inoc. | 3.70 | 0.094 | 3.53 | 0.089 | |||
| + Inoc. | 3.63 | 0.93 | 3.45 | 0.92 | |||
| 0.095 | 0.18 | ||||||
| No Inoc. | 3.79 | 0.096 | 3.65 | 0.097 | |||
| + Inoc. | 3.61 | 0.092 | 3.53 | 0.094 | |||
| COVID-19 | 0.18 | 0.44 | |||||
| No Inoc. | 3.92 | 0.096 | 3.29 | 0.102 | |||
| + Inoc. | 3.26 | 0.108 | 3.27 | 0.108 | |||
Note: One-tailed tests that inoculations are lower than regular treatment cells are reported.
Fig. 7Effects of politicization treatments on carryover confusion (HPV vaccine and COVID-19).
T-test comparisons of inoculation warnings on carryover confusion compared to politicization conditions alone.
| Carryover confusion | ||||
|---|---|---|---|---|
| Mean | SE | p | ||
| HPV Vaccine | 0.87 | |||
| No Inoculation | 3.16 | 0.095 | ||
| + Inoculation | 3.31 | 0.103 | ||
| 0.36 | ||||
| Treatment | 3.16 | 0.105 | ||
| with Inoculation | 3.11 | 0.101 | ||
| 0.029 | ||||
| No Inoculation | 3.36 | 0.109 | ||
| + Inoculation | 3.07 | 0.104 | ||
| COVID-19 | 0.077 | |||
| No Inoculation | 3.72 | 0.108 | ||
| + Inoculation | 3.50 | 0.112 | ||
Note: One-tailed tests that inoculations are lower than regular treatment cells are reported.
Fig. 8Effects of politicization treatments on carryover support for immunization program requirements (HPV vaccine and COVID-19).
T-test comparisons of inoculation warnings on carryover immunization support compared to politicization conditions alone.
| Immunization support | ||||
|---|---|---|---|---|
| Mean | SE | p | ||
| HPV Vaccine | 0.25 | |||
| No Inoculation | 5.21 | 0.079 | ||
| + Inoculation | 5.29 | 0.077 | ||
| 0.23 | ||||
| No Inoculation | 5.23 | 0.086 | ||
| + Inoculation | 5.31 | 0.079 | ||
| 0.30 | ||||
| No Inoculation | 5.29 | 0.084 | ||
| + Inoculation | 5.35 | 0.082 | ||
| COVID-19 | 0.11 | |||
| No Inoculation | 4.97 | 0.091 | ||
| + Inoculation | 5.12 | 0.089 | ||
Note: One-tailed tests that inoculations are higher than regular treatment cells are reported.
Demographics of the survey experiment sample
| Number of respondents | Percentage | |||
|---|---|---|---|---|
| Gender | Female | 1616 | 53.7% | |
| Age | 18–24 | 355 | 11.8% | |
| 25–34 | 465 | 15.5% | ||
| 35–44 | 547 | 18.2% | ||
| 45–54 | 522 | 17.3% | ||
| 55–64 | 468 | 15.6% | ||
| 65 + | 653 | 21.7% | ||
| Race | Nonwhite | 1073 | 35.6% | |
| Education | HS or less | 597 | 19.8% | |
| Some college | 844 | 28.0% | ||
| College and above | 1571 | 52.2% |
| {Base:} | {Controversy:} | {Uncertainty:} | {Political:} |
| Panel to Expand HPV Vaccine Recommendations | Controversy Erupts Over New HPV Vaccine Recommendations | Advocates Cast Doubt on Scientific Evidence Behind New HPV Vaccine Recommendations as Controversy Erupts | Political Pushback to New HPV Vaccine Recommendations as Controversy Erupts |
| {Controversy:} | {Uncertainty:} | {Political:} |
| Local advocate Jennifer Peters summed up the concerns: “Why are we requiring 10- and 11-year old kids to get a vaccine that they can get later as adults?” | In addition, local advocate Jennifer Peters cast doubt on the evidence provided for the recommended age to receive vaccination. “Researchers are always changing their minds about when to vaccinate, and the evidence is uncertain and can be used to support different positions. In this case, they know that the vaccine is fine for adults and yet they say that it has to be given to children to be effective.” Peters summed up the concerns: “Why are we requiring 10- and 11-year old kids to get a vaccine that they can get later as adults?” | Longtime politician and state senator Jennifer Peters sided with opponents of required vaccination, summing up the concerns: “Why are we requiring 10- and 11-year old kids to get a vaccine that they can get later as adults?” |
| {Base:} | {All Politicized Elements:} |
| CDC Updates Recommendations on Mask Wearing | Controversy and Political Pushback Over CDC Mask Wearing Recommendations in Light of Doubts About Scientific Evidence |